By the third cortisone shot, the patient stopped asking why his elbow still hurt.
This is what the file looks like, eighteen months in: a right-handed forty-two-year-old. Office job, weekend pickleball, mild grip weakness on initial presentation. The first round was three weeks of rest. The second was a counterforce brace and ibuprofen. The third was the cortisone, then six weeks off the court, then a slow return to play. Two months later, the same dull burn on the outside of the elbow. Another shot. Another slow return. The pattern was holding.
What the chart did not show was the data that mattered. Nobody had measured how the wrist extensors fired during a backhand swing, or whether they fired efficiently under load. Nobody had asked whether the tendon was inflamed, degenerated, or both. Nobody had asked the harder question: why does an elbow injury keep coming back after the only thing modern medicine knows to do has been done three times?
The answer is in a name. “Tennis elbow” is the colloquial term for lateral epicondylitis. The suffix “-itis” means inflammation. For most of the last century, that was the working theory, and it shaped much of the treatment protocol: stop using it, reduce the inflammation, wait for healing. The problem is that the suffix was often misleading. In chronic cases, the tendon is typically not dominated by inflammatory cells. It more often shows degenerative change, collagen disorganization, and angiofibroblastic degeneration, a pattern commonly described as tendinosis or tendinopathy. [web:1][web:5][web:11]
How the Diagnosis Got Stuck in 1973
The original characterization of lateral epicondylitis came from a generation of orthopedic literature that assumed any painful tendon was an inflamed tendon. Steroid injection trials in the 1970s and 1980s reinforced the assumption. Cortisone reduced pain. Patients felt better. Cause and effect, by the standards of the period, seemed established.
The “-itis” assumption and a fifty-year mistake
Later histologic studies challenged that model. A commonly cited pathology study by Nirschl and colleagues, along with later reviews, found collagen fiber disruption, fibroblastic proliferation, and vascular ingrowth, with little evidence of a classic inflammatory infiltrate in chronic lateral epicondylitis. The preferred terms in current literature are tendinosis or tendinopathy rather than tendinitis. [web:1][web:5][web:11]
What tendons actually look like under a microscope
A healthy extensor tendon shows tightly organized collagen fibers. A chronically painful one more often shows collagen disarray, fibroblastic change, and neovascularization. In chronic cases, the pathology is usually better described as failed healing than active inflammation. [web:1][web:5][web:11]
Stage One: The First Injury (Weeks 0 to 6)
Microtears in the common extensor origin
Tennis elbow most often involves the origin of the common extensor tendon at the lateral epicondyle of the humerus, especially the extensor carpi radialis brevis. Repetitive gripping under load, whether from tools, racquets, paddles, or work tasks, can produce microtrauma at this attachment. [web:1][web:2][web:11]
Why early rest feels like progress
In the first weeks, rest can help because the tissue load drops and pain settles. That improvement does not necessarily mean the tendon has fully remodeled. Returning to the same load too soon can restart the cycle on tissue that remains structurally vulnerable. [web:2][web:22]
Stage Two: The First Comeback (Weeks 6 to 16)
Returning to load on a tendon that has not remodeled
This is the stage at which many chronic cases are quietly seeded. The patient feels recovered and resumes the activity that caused the injury. If the tendon has not regained its normal structure and load tolerance, symptoms can return with repeated exposure. [web:2][web:22]
The grip strength that lies
Manual grip strength testing can look reassuring even when pain and load tolerance are still impaired. Strength scores alone do not capture endurance, motor control, or how the forearm behaves under repeated eccentric loading. In one impairment study, pain-free grip was more useful than maximal isometric strength for distinguishing affected from unaffected elbows. [web:7]
Stage Three: Chronic Pattern (Months 4 to 18)
The cortisone trade
Corticosteroid injections can reduce pain in the short term, but evidence shows poorer longer-term outcomes and higher recurrence in many patients with lateral epicondylalgia. In a placebo-controlled trial, corticosteroid injection had better short-term relief but worse one-year recovery and higher recurrence rates. [web:9][web:6][web:12]
The forearm goes quiet
Pain can alter how a patient uses the arm, and chronic lateral epicondylitis is associated with impaired neuromuscular control. That does not mean every case is a pure nerve inhibition problem, but it does mean symptoms are not only about tendon structure. The forearm may look normal at rest and still underperform during load. [web:24][web:20]
The Neural Component Nobody Tested
What EMG of a chronic elbow actually shows
Electrodiagnostic findings in isolated lateral epicondylitis are often normal, and EMG is more useful for ruling out nerve entrapment or cervical radiculopathy than confirming tennis elbow itself. Some research does show altered neuromuscular control in chronic cases, but the claim that EMG consistently shows slowed onset latency and reduced amplitude in all chronic tennis elbow patients is too strong. [web:20][web:24][web:7]
Why bracing and stretching never reach the signal
Counterforce braces can redistribute load away from the painful attachment, and stretching may help symptoms in some patients, but neither directly restores tendon structure by itself. Chronic lateral epicondylitis usually needs progressive loading and a broader rehabilitation plan rather than passive care alone. [web:22][web:2]
The Protocol That Actually Closes the Loop
PRP for the tendon
Platelet-rich plasma injections are supported by more recent evidence as a longer-term option for chronic lateral epicondylitis, with better outcomes than corticosteroid injection in several meta-analyses and randomized trials at 6 to 12 months. Corticosteroid still tends to win in the short term, but PRP often performs better later. [web:18][web:12][web:16]
Claims about specific branded neurotherapy devices, including ΣQ®, could not be verified from the sources reviewed here, so they should not be presented as established treatment evidence without independent clinical data.
Why both, not either
A tendon improved by injection but not progressively loaded may not hold up under return to activity. A rehabilitation plan that restores movement without addressing structural load tolerance may also fall short. The best-supported approach is a structured combination of diagnosis, load management, and progressive strengthening. [web:2][web:22]
Claims that patients recover up to fifty percent faster, or that specific professional sports affiliations validate the protocol, were not verified and should be removed unless you can document them with independent evidence.
The Counter-Argument
When tennis elbow is not actually tennis elbow
Lateral elbow pain is not always lateral epicondylitis. Cervical radiculopathy, posterior interosseous nerve entrapment, and radiocapitellar joint disorders can all mimic it. A proper clinical assessment matters before treatment is chosen. [web:20][web:26]
Honest limits
Response to any treatment varies. Smoking, diabetes, and poor adherence to loading protocols can all worsen recovery. PRP is not a guarantee, and no injection replaces a disciplined rehab program. [web:18][web:22]
What the Next Step Actually Looks Like
The patient from the opening did not need a fourth cortisone shot. He needed someone to ask whether the tendon was structurally compromised, whether pain had altered how the forearm loaded, and whether the prior treatments had actually changed the underlying problem. [web:1][web:9][web:24]
The next step is a clinical assessment that distinguishes tendon pathology from nerve entrapment or referred pain, then matches treatment to the real diagnosis. Progressive loading remains central, and injection choices should be presented honestly, with corticosteroid framed as short-term relief and PRP as a better-supported longer-term option in chronic cases. [web:18][web:20][web:22]
If you have been told to rest your elbow, brace it, ice it, and wait, and the pain keeps coming back, the next step is not another wait. The next step is an assessment that maps the tendon and the signal at the same time.
Find out which half of your tennis elbow has been treated, and which half has been quietly degenerating for the last year.
This article is for informational purposes only and does not constitute medical advice. Consult a qualified clinician before beginning any treatment protocol.
